News Archive

Every report the desk has filed, searchable by full text, topic, format, symbol and date range.

Filtering:SNY

Sanofi to pay Regeneron up to $8 billion to expand Dupixent antibody pipeline

The deal adds new antibody candidates to the companies' blockbuster Dupixent partnership and sent Sanofi shares higher.

Sanofi agreed to pay Regeneron up to $8 billion to bring additional antibodies into their existing Dupixent collaboration, and Sanofi stock rallied on the news.

BREAKING STORYBULLISH01 Oct 2026

EnergySNY REGNRead report →

Sanofi Adds $1 Billion Upfront In Expanded Regeneron Alliance

The French drugmaker and its US partner widened a deal that could be worth up to $8 billion as both companies push deeper into shared drug development.

Sanofi and Regeneron expanded their partnership in a deal that includes a $1 billion upfront payment and a total value of up to $8 billion.

BREAKING STORYBULLISH01 Oct 2026

Healthcare & PharmaSNY REGNRead report →

Most covered symbols

NVDA GSPC MU TNX AMD GOOGL BTC BTC-USD AVGO META MSFT IXIC AAPL TLT AMZN BABA CL=F GLD TSLA CRWV CL COIN INTC 000660.KS BA MSTR USDJPY USO DELL DXY NBIS PLTR SNDK NDX ETH HOOD ORCL RKLB TSM WBD

Each chip opens the Research terminal for that symbol, where its archive coverage is listed alongside the fundamentals.